BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16403551)

  • 1. An exposure assessment for selected pharmaceuticals within a watershed in Southern Ontario.
    Lissemore L; Hao C; Yang P; Sibley PK; Mabury S; Solomon KR
    Chemosphere; 2006 Jul; 64(5):717-29. PubMed ID: 16403551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain).
    Ginebreda A; Muñoz I; de Alda ML; Brix R; López-Doval J; Barceló D
    Environ Int; 2010 Feb; 36(2):153-62. PubMed ID: 19931909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial ecological risk assessment of eight selected human pharmaceuticals in Japan.
    Yamamoto H; Nakamura Y; Nakamura Y; Kitani C; Imari T; Sekizawa J; Takao Y; Yamashita N; Hirai N; Oda S; Tatarazako N
    Environ Sci; 2007; 14(4):177-93. PubMed ID: 17762841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters.
    Sanderson H; Johnson DJ; Reitsma T; Brain RA; Wilson CJ; Solomon KR
    Regul Toxicol Pharmacol; 2004 Apr; 39(2):158-83. PubMed ID: 15041147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity assessment of wastewaters, river waters, and sediments in Austria using cost-effective microbiotests.
    Latif M; Licek E
    Environ Toxicol; 2004 Aug; 19(4):302-9. PubMed ID: 15269900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrate concentrations in river waters of the upper Thames and its tributaries.
    Neal C; Jarvie HP; Neal M; Hill L; Wickham H
    Sci Total Environ; 2006 Jul; 365(1-3):15-32. PubMed ID: 16618496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceuticals and other organic chemicals in selected north-central and northwestern Arkansas streams.
    Haggard BE; Galloway JM; Green WR; Meyer MT
    J Environ Qual; 2006; 35(4):1078-87. PubMed ID: 16738393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of pharmaceuticals in contaminated urban wastewater effluent under ultrasonic irradiation.
    Naddeo V; Meriç S; Kassinos D; Belgiorno V; Guida M
    Water Res; 2009 Sep; 43(16):4019-27. PubMed ID: 19589554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecotoxicology of human pharmaceuticals.
    Fent K; Weston AA; Caminada D
    Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report on interspecies quantitative correlation of ecotoxicity of pharmaceuticals.
    Kar S; Roy K
    Chemosphere; 2010 Oct; 81(6):738-47. PubMed ID: 20692010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceuticals in the river Elbe and its tributaries.
    Wiegel S; Aulinger A; Brockmeyer R; Harms H; Löffler J; Reincke H; Schmidt R; Stachel B; von Tümpling W; Wanke A
    Chemosphere; 2004 Oct; 57(2):107-26. PubMed ID: 15294435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan.
    Lin AY; Yu TH; Lin CF
    Chemosphere; 2008 Dec; 74(1):131-41. PubMed ID: 18829065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal variation of pharmaceuticals in an urban and agriculturally influenced stream.
    Veach AM; Bernot MJ
    Sci Total Environ; 2011 Oct; 409(21):4553-63. PubMed ID: 21855963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
    Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):88-95. PubMed ID: 16260028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals in on-site sewage effluent and ground water, Western Montana.
    Godfrey E; Woessner WW; Benotti MJ
    Ground Water; 2007; 45(3):263-71. PubMed ID: 17470115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.
    Choi K; Kim Y; Park J; Park CK; Kim M; Kim HS; Kim P
    Sci Total Environ; 2008 Nov; 405(1-3):120-8. PubMed ID: 18684486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogenous photocatalytic degradation kinetics and detoxification of an urban wastewater treatment plant effluent contaminated with pharmaceuticals.
    Rizzo L; Meric S; Guida M; Kassinos D; Belgiorno V
    Water Res; 2009 Sep; 43(16):4070-8. PubMed ID: 19596131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of pharmaceuticals in Taiwan's surface waters: impact of waste streams from hospitals and pharmaceutical production facilities.
    Lin AY; Tsai YT
    Sci Total Environ; 2009 Jun; 407(12):3793-802. PubMed ID: 19345984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
    Straub JO
    Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.